SCHEMBL5728166

SCHEMBL5728166

CCCCC(=O)Nn1c(C(=O)O)cc2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.50
DAO P14920 1/20 0.48
ADORA1 P30542 1/20 0.47
CCR2 P41597 2/20 0.46
ALDH1A1 P00352 4/20 0.46
TSHR P16473 1/20 0.46
CYP1A2 P05177 1/20 0.44
POLB P06746 1/20 0.44
HPGD P15428 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
OXER1 Q8TDS5 5/20 0.43
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PLA2G4A P47712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25186849 0.83 DAO (0.50) MCL1DAOCCR2ALDH1A1TSHR
SCHEMBL29758037 0.82 CCR2 (0.54) MCL1DAOCCR2ALDH1A1TSHR
SCHEMBL5008889 0.81 MCL1 (0.50) MCL1DAOCCR2ALDH1A1TSHR
SCHEMBL10379817 0.79 DAO (0.59) MCL1DAOCCR2ALDH1A1TSHR
SCHEMBL8551062 0.79 MCL1 (0.57) MCL1DAOCCR2ALDH1A1TSHR
SCHEMBL8639593 0.78 MCL1 (0.47) MCL1DAOCCR2ALDH1A1TSHR
SCHEMBL25195555 0.76 MCL1 (0.48) MCL1DAOCCR2ALDH1A1TSHR
SCHEMBL25195634 0.75 MCL1 (0.53) MCL1DAOCCR2ALDH1A1TSHR
SCHEMBL10757133 0.74 ALDH1A1 (0.66) MCL1DAOCCR2ALDH1A1TSHR
SCHEMBL6682164 0.73 ALDH1A1 (0.64) MCL1DAOCCR2ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633746-A1 NEW INDOLE DERIVATIVES AS FACTOR XA INHIBITORS Sanofi-Aventis Deutschland GmbH (DE) 2006-03-15 EP disclosed
WO-2004101554-A1 NEW INDOLE DERIVATIVES AS FACTOR XA INHIBITORS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2004-11-25 WO disclosed
EP-1451185-A1 INDOLE-2-CARBOXAMIDES AS FACTOR XA INHIBITORS Aventis Pharma Deutschland GmbH (DE) 2004-09-01 EP disclosed
WO-2003044014-A1 INDOLE-2-CARBOXAMIDES AS FACTOR XA INHIBITORS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-05-30 WO disclosed